連花清瘟膠囊具有清瘟解毒、宣肺泄熱的功效,臨床用于治療流行性感冒屬熱毒襲肺證,在抗擊新型冠狀病毒肺炎疫情期間發(fā)揮了重要作用,成為國(guó)家診療方案、各省治療方案推薦的中成藥。從藥理作用以及臨床應(yīng)用兩個(gè)方面來(lái)總結(jié)連花清瘟膠囊(顆粒)抗新型冠狀病毒、流感病毒、呼吸道合胞病毒、腸道病毒、皰疹病毒等的研究進(jìn)展,以期對(duì)連花清瘟膠囊(顆粒)抗病毒作用的研究現(xiàn)狀有新的認(rèn)識(shí),從而更好地推進(jìn)其抗病毒的深入研究,更加合理地應(yīng)用于臨床。

Lianhua Qingwen Capsule has the effect of clearing away the plague and detoxification, purging the lung and discharging heat, and it is used to treat influenza which belongs to the syndrome of heat toxin attacking the lung. Since the outbreak of COVID-19 infection, Lianhua Qingwen have played a significant role, and has become a traditional Chinese patent medicines which recommended by the national diagnosis and treatment plan and provincial treatment plan. The authors have summarized the research progress of Lianhua Qingwen Capsule (Granule) against severe acute respiratory syndrome coronavirus 2, influenza virus, respiratory syncytial virus from the perspective of pharmacological effect and clinical application, in order to have a new understanding of the research status of Lianhua Qingwen Capsule (Granule)'s against virus effect, so as to better guide the antiviral research of Lianhua Qingwen Capsule (Granule).

R285.5;R969.3

國(guó)家自然科學(xué)基金資助項(xiàng)目(82003932);中央引導(dǎo)地方科技發(fā)展資金項(xiàng)目(桂科ZY21195044);廣西重點(diǎn)研發(fā)計(jì)劃項(xiàng)目(桂科AB20159029);廣西中醫(yī)藥大學(xué)基金項(xiàng)目(2023BS058)